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Introduction
Idiopathic Thrombocytopenic Purpura, or Immune
Thrombocytopenia (ITP), as new guidelines suggest, is an
acquired autoimmune disease characterised by platelet
destruction, caused by anti-platelet auto antibodies.1
Spleen is the main reticuloendothelial system where anti-
platelet antibodies are produced and autoantibody-
platelet complex is destroyed.2-5
Medical treatment is chosen as a first line or initial
treatment for ITP, especially corticosteroids.2,3,6
Splenectomy is performed for various haematological
disorders and has been a well-recognised therapeutic
modality since years.7,8 The first reported splenectomy
done for ITP was in 1916.1,9 Splenectomy is opted in
patients who do not respond to medical treatment or
when the side-effects of medical therapy are
unacceptable or in case of relapse.2,5,6,10
There can be some pre-operative parametres that are able
to predict the response to splenectomy. They are not fully
recognised in literature and hence the clinical value of any
pre-operative characteristic is unknown.2,5 Furthermore,
laparoscopic splenectomy, first introduced by Delaitre
and Maignein in 1991 has evolved over the years as
standard procedure compared to open one.10 Literature
has shown its advantage over the open technique.11,12
Many patients succumb to adverse effects of medical
therapy in order to have a sustained response, which
increases burden on healthcare, cost of treatment and
anxiety in patients and families. Splenectomy may be a
safe alternative in such situations especially in developing
countries like Pakistan. There is paucity of literature
regarding outcomes of splenectomy done for ITP and the
predictors of response from our country. Therefore, we
report a retrospective study to determine the outcomes
of splenectomy done in adult patients of ITP over a period
of 10 years. Secondary objective was to determine the
predictors of complete response to therapy.
Patients and Methods
The retrospective review comprised adult patients over 14
years of age who underwent open or laparoscopic
splenectomy for ITP at Aga Khan University Hospital over
10 years from January 2000 to December 2010. The files
were reviewed in January 2011 by a surgical resident.
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Abstract
Objective: to determine the outcome of splenectomy done in adult patients of Idiopathic Thrombocytopenic
Purpura over a period of 10 years and, secondarily, to determine the predictors of complete response to therapy. 
Methods: The retrospective review comprised of adult patients over 14 years of age who underwent open or
laparoscopic splenectomy for Idiopathic Thrombocytopenic Purpura at Aga Khan University Hospital, Karachi, from
January 2000 to December 2010. Data was reviewed in January 2011 by a surgical resident. Outcome was the
response to splenectomy as per new definition of response set by the American Society of Haematology 2011
evidence based practice guidelines for Idiopathic Thrombocytopenic Purpura. Assessment of response was done
within 1 to 2 months of splenectomy and after withholding concomitant treatment. SPSS 17 was used for statistical
analysis.
Results: A total of 27 patients were found eligible. Of them, 2(7.4%) were males and 25(92.6%) were females with an
overall mean age at the time of splenectomy of 30.8±6.3 years (range: 15-55 years). Out of 27 cases, 23(85.18%)
patients underwent open splenectomy, 3(11%) laparoscopic and 1(3.7%) had laparoscopic converted to open
splenectomy. Complete response was achieved in 20(74.1%) patients, whereas 5(18.5%) had response and 2(7.4%)
had no response. None of the predictors of response to splenectomy were found significant. 
Conclusion: Response to splenectomy in adult Idiopathic Thrombocytopenic Purpura patients was comparable to
reported rate in literature with relatively lower morbidity and mortality. Splenectomy is a safe treatment option
especially in patients who succumb to adverse effects of medical therapy. 
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Initially files of patients who underwent splenectomy
were retrieved through International Classification of
Diseases (ICD) codes. Patients who underwent
splenectomy due to trauma or other haematological
disorders or diseases were excluded, so were the patients
with incomplete or missing records.
To assess the response to splenectomy for ITP the new
definition of response set by American Society of
Haematology 2011 evidence-based practice guidelines
for ITP(9) was used; complete response meant achieving
post-splenectomy platelet counts of at least 100x109/L
without treatment; response meant achieving post-
splenectomy platelet counts between 30x109/L and
100x109/L or at least doubling of the baseline count
without treatment; and no response meant platelet
counts <30x109 or less than doubling of baseline count.
Assessment of response was done within 1 to 2 months of
splenectomy and after withholding concomitant
treatment. The pre-splenectomy and post-splenectomy
cell counts were selected as minimum value and
maximum levels achieved, respectively, in order to assess
the patients response. The predictors of response
reviewed were age, gender, pre-operative platelet count,
treatment regimen used before splenectomy, duration
between diagnosis and splenectomy.
As a practice, all patients who underwent elective
splenectomy received pneumococcal vaccine prior to
surgery.
Statistical analysis was done on SPSS 17. Continuous
variables were analysed as means with standard
deviations and t-test was used. Categorical variables were
analysed as frequencies and percentages and chi-square
test was applied to see any association between
predictors and response. A p-value of less than 0.05 was
considered to be statistically significant.
Results
There were a total of 158 adult patients who underwent
the procedure. Of them 48(3-.37%) patients were
operated for different haematological disorders. Of the 48
cases, 27(56.25) operated for ITP were found eligible for
review and analysis. From within the study population,
2(7.4%) were males and 25(92.6%) were females with an
overall mean age at the time of splenectomy of 30.8±6.3
years (range: 15-55 years). Elective splenectomy was
performed in 26(96.3%) patients, whereas 1(3.7%) patient
presented in emergency. All patients had radiology done,
either ultrasound or computed tomography (CT) scan
abdomen (Table-1). All the patients had normal-sized
spleen. No accessory spleen was seen at radiology. Of the
total, 25(92.6%) patients had received medical treatment
prior to surgery as first line of treatment. Out of these 25
patients, 22(88%) had steroids only, whereas 3(12%) had
steroids and azathioprine. 
Out of 27 cases, 23(85.2%) patients underwent open
splenectomy, 3(11.11%) laparoscopic and 1(3.7%) had
laparoscopic converted to open splenectomy. Most of the
cases of splenectomy were done in less than 2 hours
(n=19; 70.4%) and rest of the cases were done in 2-3 hours
(n=8; 29.7%). Majority of patients (n=25; 92.6%) were
discharged within 10 days. Only 1(3.7%) patient had post-
operative complication, while 26(96.3) had uneventful
post-operative course (Table-2). 
Complete response was achieved in 20(74.1%) patients,
whereas response was noticed in 5(18.5%) and no
response in 2(7.4%). The association of predictors with
response (complete or partial) was also worked out
(Table-3). The only significant association was found with
pre-splenectomy medical therapy received. Patients who
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Table-1: Showing demographic data of the patients.
Patient Characteristics No. of cases and percentages
Gender
Males 2 (7.4%)
Females 25 (92.6%)
BMI (kg/m2)
16.6-18.4 1(3.7%)
18.5-24.9 13(48.1%)
25-30 7(25.9%)
30.1-34.9 4(14.8%)
35-40 2(7.4%)
Mode of presentation
Elective 26 (96.3%)
Emergency 01(3.7%)
Radiology
Ultrasound 26 (96.3%)
CT abdomen 01 (3.7%)
Duration b/w diagnosis and splenectomy
<1 year 16(59.3%)
1-5 years 9(33.3%)
6-10 years 2(7.4%)
Treatment regimen before splenectomy
Steroids only 22(81.5%)
Steroids+Azathioprine 3(11.1%)
No treatment 2(7.4%)
Pre-operative platelet count (/L)
01-05 x 10^9/L 8 (29.6%)
06-10 X10^9/L 6(22.2%)
11-20 X10^9/L 3(11.1%)
21-50 X10^9/L 5(18.5%)
51-100 X10^9/L 4(14.8%)
151-400 x10^9/L 1(3.7%)
were on steroids (with complete or partial response but
suffered adverse effects) had significantly higher
response.
Discussion
The retrospective review shows the results of
splenectomy done for ITP at a tertiary care centre of a
developing country, with 74.1% patients showing
complete response and 18.5% with partial response. With
the evolution of laparoscopic splenectomy, we have also
undertaken a couple of successful laparoscopic
procedures with encouraging results. 
We found that females were more affected with ITP than
males which are comparable to other data.13
Splenectomy has been the second-line treatment and
apparently curative for adult patients with ITP, who do not
respond to medical therapy.6 Corticosteroids and
combination of corticosteroid plus azathioprine is the
first-line treatment for ITP patients as we recorded in our
study, however, as observed all the 25 patients receiving
the medical therapy had to undergo splenectomy. Prior
case series have reported a relapse of around two-third of
patients in whom medical therapy failed.13
The expected immediate response given in literature is
70-85% postsplenectomy.9 This study showed response in
92.6% patients, whereas 7.4% did not show response.
None of the patients had relapse in their follow-up. Only
one (3.7%) patient had atelectasis as post-operative
complication, whereas 26 (96.3%) had uneventful
recovery time. This is encouraging in comparison with the
literature which reports the morbidity rate of up to
12.9%.5 We did not encounter any patient having
overwhelming post-splenectomy infection.
Studies are done over the past decade to establish
prognostic predictors of response to splenectomy. Our
study has shown that failure to response to steroids is a
risk factor for failure of response to splenectomy, Previous
studies have shown age and duration between diagnoses
to splenectomy to be the positive prognostic
parameters;13 however, our study does not reveal such an
association. This may be due to limited sample size and
power of the study. 
The study had its limitations. Being a retrospective study
of ten years, it had data that was not basically
documented for research purpose. Hence, there were
some variations in parametres i.e. follow-up period, post-
operative platelet surveillance etc. As per institutional
policy, files of patients with no activity for five years are
destroyed and only key documents are scanned, hence
making them unsuitable for research purposes. Due to
this reason, our sample size was small and inappropriate
to determine associations of predicting factors. These
limitations can be overcome by a prospective and/or
multicentre study.
Conclusion
The response to splenectomy in adult ITP patients was
comparable to reported rate in literature with relatively
lower morbidity and mortality. Splenectomy is a safe
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Table-2: Showing surgery related data and outcomes of patients.
Variable No. of cases and percentages
Route of surgery
Open 23 (84.4%)
Laparoscopic 2 (7.4%)
Hand assisted laparoscopic surgery 1 (3.7%)
Laparoscopic converted to open 1 (3.7%)
Duration of surgery (hours)
1-2 hours 19 (70.4%)
2-3 hours 8 (29.6%)
Response
Complete response 20 (74.1%)
Response 5 (18.5%)
No response 2 (7.4%)
Hospital stay(days)
5-Jan 15 (45.6%)
10-Jun 10 (37%)
>10 2 (7.4%)
Post-operative complications
None 26 (96.3%)
Atelectasis 1 (3.7%)
Table-3: Significance of factors predicting splenectomy response.
Predictors of Response P value
response Complete (n=20) Response (n=5) No (n=2)
Age
Up to 40 17 (85%) 3 (60%) 1 (50%) 0.3
41 and above 3 (15%) 2(40%) 1 (50%)
Gender
Male 1 (5%) 1(20%) 0 0.476
Female 19 (95%) 4 (80%) 2 (100%)
Pre-operative platelet count
Up to 10 9 (45%) 3 (60%) 2 (100%) 0.306
11 and above 11 (55%) 2 (40%) 0
Duration b/w diagnosis & splenectomy
<1 year 11 (55%) 3 (60%) 2 (100%)
1-5 years 7 (35%) 2 (40%) 0 0.723
6-10 years 2 (10%) 0 0
Treatment Regimen
Steroids only 18 (90%) 3 (60%) 1 (50%)
Steroids+Azathioprine 1 (5%) 2 (40%) 0 0.029
No treatment 1 (5%) 0 1 (50%)
treatment option especially in patients who succumb to
adverse effects of medical therapy. 
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